drugset / Trial / NCT00528918
Comparison of Apidra to Regular Insulin in Hospitalized Patients
RandomizedSingle-groupTriple-blindTreatment
Summary
The purpose of this study is to compare Apidra (a rapid acting insulin analogue) with Regular insulin (fast acting) in addition to the use of long acting insulin Glargine in hospitalized patients in terms of efficacy and safety in blood glucose control and frequency of low blood glucose. Blood glucose control along with incidence and rate of low blood glucose during the hospitalization shall be of primary interest; length of hospital stay comparing the short acting insulin used shall be the secondary interest.
Timeline
- Start
- 2007-06
- Primary completion
- 2011-05
- Completion
- 2011-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Insulin glulisine | Protein / enzyme biologic | 0.2 iu/kg | — |
| Comparator | Insulin glulisine | Protein / enzyme biologic | 0.25 iu/kg | — |
| Comparator | Insulin glulisine | Protein / enzyme biologic | 0.3 iu/kg | — |